UCSF CLINICAL RESEARCH CURRICULUM AWARD

描述（由申请人提供）： 自1999年获得我们的第一个K30奖以来，UCSF临床研究培训计划（TICR）已经朝着我们增加临床研究者的数量，多样性和质量的目标取得了很大进展。 通过我们的修订和扩大8周的临床研究研讨会，我们正式的1年临床研究证书课程高级培训，以及我们新的2年临床研究硕士学位课程，我们在过去5年中培训了700多名新的临床研究人员。 这涉及到增加正式UCSF课程的数量从2到24;创建一个结构化的方法来指导;通过发布广泛使用的文本和创建一个开放访问的网站传播我们的教学方法;并使用学生的评价和同行的建议，以不断提高我们的战略和性能。 我们的理念是邀请学生创建参与临床研究的实际产品：例如，对于我们的基石临床研究研讨会，每个学者为实际研究设计一个协议;对于我们的硕士学位，她/他设计，进行，分析，提交并发表临床研究。 在未来5年，我们计划继续所有这些成功的计划和战略，并以多种方式加强和扩大它们。 我们正在开发2个新的学位课程：与加州大学伯克利分校公共卫生学院的联合博士学位，以及为UCSF医学生提供的新的5年制MD硕士学位。 我们计划改进我们现有的每门课程，我们将创建6门新课程，包括遗传流行病学和统计遗传学的3个季度系列。 我们的目标是增加一倍的硕士学者每年录取的数量（N=20），特别注意增加来自代表性不足的UCSF部门和种族背景的人数。 我们将为学者们创造一个观察和讨论IRB如何运作的机会，并开始要求MCR候选人口头辩护他们的论文，并向他们的委员会展示方法的掌握。 我们计划创新，以加强辅导和职业发展，包括导师，每周研究诊所，半年度职业发展论坛结构化指导。 目前正在编写几本新教材，我们将采取措施，让其他机构更多地使用我们的教材。 新的焦点小组，离职面谈和校友聚会将加强我们的评估过程，我们将利用这些信息和建议，从内部和外部咨询委员会和同事在其他K30计划在一个持续的9努力，以改善我们的计划。

DESCRIPTION (provided by applicant): Since receiving our first K30 award in 1999, the UCSF Training In Clinical Research program (TICR) has made great progress toward our goal of increasing the number, diversity and quality of clinical investigators. Through our revised and expanded 8-week Clinical Research Workshop, our formalized 1-year Advanced Training in Clinical Research Certificate Program, and our new 2-year Master's in Clinical Research Degree Program, we have trained over 700 new clinical researchers during the last 5 years. This has involved increasing the number of formal UCSF courses from 2 to 24; creating a structured approach to mentoring; disseminating our teaching methods by publishing widely-used texts and creating an open-access website; and using student evaluations and advice from peers to continuously improve our strategies and performance. Our philosophy is to invite students to create the actual products involved in clinical research: For our cornerstone Clinical Research Workshop, for example, each scholar designs a protocol for an actual study; for our Master's Degree she/he designs, conducts, analyzes, presents and submits for publication a clinical research study. During the next 5 years, we plan to continue all these successful programs and strategies, and to enhance and expand on them in a number of ways. We are developing 2 new degree programs: a joint PhD with the UC Berkeley School of Public Health, and a new 5-year MD-Master's Degree option for UCSF medical students. We plan improvements in each of our existing courses, and we will create 6 new courses including a 3-quarter series in genetic epidemiology and statistical genetics. We aim to double the number of master's scholars matriculating each year (to N=20), with particular attention to increasing the numbers from underrepresented UCSF departments and racial backgrounds. We will create an opportunity for scholars to observe and discuss how an IRB operates, and begin requiring MCR candidates to orally defend their thesis and demonstrate methodological mastery to their Committee. We plan innovations to enhance mentoring and career development including structured guidance for mentors, weekly research clinics, and semiannual career development forums. Several new texts are in progress, and we will take steps to increase the use of our teaching materials by other institutions. New focus groups, exit interviews, and alumni reunions will enhance our evaluation process, and we will use this information and advice from internal and external advisory committees and colleagues at other K30 programs in an ongoing 9 effort to improve our program.